Page last updated: 2024-08-24

3-iodobenzylguanidine and Parkinson Disease

3-iodobenzylguanidine has been researched along with Parkinson Disease in 202 studies

Research

Studies (202)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (5.45)	18.2507
2000's	73 (36.14)	29.6817
2010's	93 (46.04)	24.3611
2020's	25 (12.38)	2.80

Authors

Authors	Studies
An, YS; Chang, J; Kim, JW; Park, DG; Yoon, JH	1
Booij, J; Geibl, FF; Janzen, A; Kogan, RV; Leenders, KL; Luster, M; Mayer, G; Meles, SK; Oertel, WH; Renken, RJ; Sittig, E; Stormezand, G	1
An, YS; Chang, J; Kang, J; Park, DG; Yoon, JH	1
Bösch, S; Djamshidian, A; Donnemiller, E; Eckhardt, C; Eschlböck, S; Fanciulli, A; Kiechl, S; Krismer, F; Mair, K; Metzler, B; Poewe, W; Raccagni, C; Scherfler, C; Seppi, K; Uprimny, C; Virgolini, I; Wenning, GK	1
Booij, J; Geibl, F; Habibi, M; Henrich, MT; Janzen, A; Librizzi, D; Luster, M; Mayer, G; Oertel, W; Sittig, E; Timmermann, L; Vadasz, D	1
Andersen, KB; Beier, CP; Borghammer, P; Fedorova, TD; Horsager, J; Knudsen, K; Otto, M; Skjærbæk, C; Sommerauer, M; Svendsen, KB	1
Hanakawa, T; Hatano, K; Hatano, T; Hattori, N; Hayashi, T; Ikenaka, K; Ikeuchi, T; Inoue, Y; Iwaki, H; Kadotani, H; Kajiyama, Y; Kamei, Y; Kawabata, K; Matsuda, H; Mochizuki, H; Mukai, Y; Murata, M; Nakamura, T; Nishikawa, N; Saitoh, Y; Sakamoto, T; Sawamoto, N; Shimo, Y; Sumi, Y; Tachimori, H; Takahashi, R; Takahashi, Y; Taruno, Y; Watanabe, H	1
Akamatsu, W; Fujimaki, M; Hattori, N; Imamichi, Y; Iseki, T; Kamagata, K; Kataura, T; Matsumoto, H; Miyamoto, K; Saiki, S; Sasazawa, Y; Shiina, K; Suzuki, A; Ueno, SI; Yamashita, Y	1
An, YS; Kim, MS; Park, DG; Yoon, JH	1
Ebina, J; Hirayama, T; Ishii, N; Kano, O; Kawabe, K; Kobayashi, Y; Mizumura, S; Morioka, H; Nagasawa, J; Orimo, S; Shibukawa, M; Yanagihashi, M	1
An, YS; Chang, J; Kim, JY; Kim, MH; Kim, MS; Park, DG; Yoon, JH	1
Carli, G; Janzen, A; Kogan, RV; Leenders, KL; Meles, SK; Oertel, WH; Perani, D; Sittig, E	1
Saiki, S	1
Fujita, H; Nozawa, N; Ogaki, K; Sakuramoto, H; Shiina, T; Suzuki, K	1
Ikeda, T; Ikenoshita, S; Masuda, T; Nakahara, K; Sakamoto, F; Shiraishi, S; Yamashita, S	1
Iguchi, Y; Komatsu, T; Matsuno, H; Murakami, H; Nakahara, A; Oka, H; Omoto, S; Sato, T; Shiraishi, T; Umehara, T	1
Farcomeni, A; Frantellizzi, V; Pani, A; Pontico, M; Ricci, M; Vincentis, G	1
Cheon, SM; Jeong, JE; Jeong, YJ; Kang, DY; Kim, JW; Yoon, BA	1
Bono, K; Iguchi, Y; Komatsu, T; Maku, T; Mitsumura, H; Motegi, H; Murakami, H; Nakada, R; Omoto, S; Sakai, K; Sato, T; Shiraishi, T; Takahashi, M; Takatsu, H; Umehara, T	1
Boura, I; Bourogianni, O; Kapsoritakis, N; Koukouraki, S; Mitsias, P; Papadaki, E; Simos, P; Spanaki, C; Stathaki, M; Tsaroucha, A	1
Borrazzo, C; Farcomeni, A; Ferrari, C; Frantellizzi, V; Lavelli, V; Pacilio, M; Pani, R; Rubini, G; Sardaro, A; Vincentis, G	1
Calandra-Buonaura, G; Cason, E; Cortelli, P; Devigili, G; Donadio, V; Eleopra, R; Giannini, G; Giannoccaro, MP; Incensi, A; Liguori, R; Rizzo, G	1
Daida, K; Funayama, M; Hattori, N; Ishiguro, M; Ishiguro, Y; Li, Y; Nishioka, K; Oyama, G; Saiki, S; Yoshino, H	1
Brumberg, J; Buck, A; Doppler, K; Isaias, IU; Kuzkina, A; Lapa, C; Mammadova, S; Sommer, C; Volkmann, J	1
Foley, RW; Graham, RN; Laurence, IJ; Little, D; Redman, SL	1
Choi, YY; Jang, W; Kim, CK; Kim, HT; Kim, JY; Kim, TY; Lee, JY; Lee, SJ	1
Baba, Y; Hashimoto, J; Koide, T; Ryo, M; Yoshii, F	1
Harada, M; Izumi, Y; Kaji, R; Kunikane, Y; Otomi, Y; Otsuka, H; Sako, W; Shinya, T; Takashi, S; Uyama, N; Watanabe, Y	1
Orimo, S	6
Hashimoto, J; Kohara, S; Moriya, Y; Ohnuki, T; Ryo, M; Takahashi, W; Yoshii, F	1
Choi, MH; Yong, SW; Yoon, JH	1
Fujimaki, M; Funayama, M; Hatano, T; Hattori, N; Imamichi, Y; Ishikawa, KI; Kaga, N; Koinuma, T; Li, Y; Miura, Y; Mori, A; Oji, Y; Okuzumi, A; Saiki, S; Taka, H; Ueno, SI; Ueno, T	1
Huo, L; Li, F; Wang, H; Xu, D; Zhu, S; Zhu, W	1
Kim, JS; Lee, JE; Lee, KS; Oh, YS; Ryu, DW; Yoo, IR	1
Dillmann, U; Ezziddin, S; Fassbender, K; Leppert, D; Schaefer-Schuler, A; Soboll, L; Spiegel, J	1
Brandl, SJ; Braune, S	1
Alves Do Rego, C; Anheim, M; Lagha-Boukbiza, O; Lefebvre, F; Marcel, C; Namer, IJ; Renaud, M; Tranchant, C	1
Hasegawa, Y; Maki, F; Nakamura, H; Nakashima, Y; Okada, Y; Sasaki, N; Sasaki, O; Shiraishi, M	1
Acera, M; Concha, TP; Cortés, J; Del Pino, R; Fernández, M; Gabilondo, I; Gómez-Esteban, JC; Llorens, V; Murueta-Goyena, A; Rodriguez, T; Tijero, B	1
Hoshino, T; Irie, KI; Kamada, T; Kida, H; Miura, S; Taniwaki, T; Yamanishi, Y	1
Kim, JS; Lee, JE; Lee, KS; Oh, YS; Ryu, DW; Yoo, IR; Yoo, SW	1
Hwang, EJ; Kim, JS; Lee, KS; Lyoo, CH; Oh, YS; Yoo, SW	1
Berg, D; Postuma, RB	1
Asayama, S; Asayama, T; Fujita, K; Ito, H; Kaneko, S; Kusaka, H; Morita, J; Nagashima, M; Nakamura, M; Nakamura, S; Nakano, S; Nishii, M; Oki, M; Saito, A; Tsuge, A; Wate, R	1
Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Tomita, S; Umemura, A; Yamamoto, K	1
Antonio, R; Lucio, CG; Luigi, M; Oscar, T; Vincenzo, C	1
Chiaravalloti, A; Pierantozzi, M; Schillaci, O; Stanzione, P; Stefani, A	1
Hayashi, H; Horie, M; Mitsunami, K; Nakae, I	1
Berganzo, K; Gómez Esteban, JC; Lezcano, E; Llorens, V; Martinez, A; Rodríguez, T; Somme, J; Tijero, B; Zarranz, JJ	1
Ahn, JY; Cho, JW; Choi, YY; Jang, W; Kim, HT; Kim, JS	1
Carotenuto, R; Cuocolo, A; De Leva, MF; De Michele, G; De Rosa, A; Filla, A; Fiumara, G; Maddaluno, G; Pappatà, S; Pellegrino, T; Petretta, M	1
Behnke, S; Dillmann, U; Faßbender, K; Guidez, D; Halmer, R; Hellwig, D; Kirsch, CM; Spiegel, J	1
Buongiorno, MT; Compta, Y; Gaig, C; Lomeña, F; Martí, MJ; Muxi, A; Navarro-Otano, J; Tolosa, E; Valldeoriola, F	1
Inaoka, T; Kishi, M; Sakakibara, R; Tateno, F; Terada, H; Tsuyusaki, Y	1
Amaral, C; Azevedo, JC; Brito, AS; Leite, MA; Mesquita, CT; Nascimento, OJ; Pedras, FV; Pereira, JS	1
Akiyama, N; Kobayashi, K; Maeda, T; Nakano, H; Yamamori, S	1
Agostini, D; Defer, GL; Lamotte, G; Lebasnier, A; Morello, R	1
Matsuno, H; Oka, H; Toyoda, C; Umehara, T	1
Choi, EK; Chung, YA; Kim, JS; Oh, JK; Song, IU	1
Chiaravalloti, A; Galati, S; Lauretti, B; Olivola, E; Pierantozzi, M; Pisani, V; Prosperetti, C; Rocchi, C; Schillaci, O; Stampanoni Bassi, M; Stefani, A	1
Ebihara, Y; Ishii, N; Mochizuki, H; Nagamachi, S; Nakazato, M; Shiomi, K; Taniguchi, A; Ugawa, Y	1
Cameron, A; Hayhow, B; Middlemost, M	1
Aiba, Y; Doi, H; Inaoka, T; Kishi, M; Ogata, T; Sakakibara, R; Suzuki, Y; Tateno, A; Tateno, F; Tateno, H; Terada, H; Tuyusaki, Y	1
Barone, P; Cuocolo, A; De Michele, G; De Rosa, A; Pappatà, S; Pellecchia, MT; Pellegrino, T; Peluso, S; Saccà, F	1
Ebihara, Y; Ishii, N; Mochizuki, H; Nakazato, M; Nakazato, Y; Shiomi, K; Sugiyama, T; Taniguchi, A	1
Asahi, T; Kashiwazaki, D; Kuroda, S; Noguchi, K; Yoneyama, T	1
Ahn, JY; Cho, JW; Choi, YY; Kang, SJ; Kim, HT; Kim, JS; Kim, JY	1
Kim, JS; Lee, KS; Lee, SH; Oh, YS; Park, HE; Park, JW; Son, BC	1
Aoki, M; Baba, T; Hasegawa, T; Iizuka, O; Inoue, K; Kikuchi, A; Matsuda, M; Mori, E; Nishio, Y; Odagiri, H; Takeda, A; Taki, Y	1
Iikuni, Y; Ito, H; Kang, Y; Morimatsu, A; Murakami, T; Shirata, A; Ugawa, Y; Yamada, A; Yamane, K	1
Dillmann, U; Ezziddin, S; Fassbender, K; Haqparwar, J; Leppert, D; Pepe, A; Schaefer, A; Spiegel, J	1
Calcagnini, G; Censi, F; Colosimo, C; De Vincentis, G; Fanciulli, A; Marinelli, P; Meco, G; Palange, P; Rizzo, M; Strano, S; Tiple, D	1
Araki, N; Matsunari, I; Nakano, S; Niitsu, M; Nishimura, S; Okano, N; Sasaki, T; Senbonmatsu, T; Takahashi, K; Tanaka, J; Yamamoto, T	1
Fujita, H; Hirata, K; Miyamoto, M; Miyamoto, T; Numao, A; Suzuki, K; Uchiyama, T; Watanabe, Y	1
Choi, HS; Jung, YA; Kim, JS; Lee, KS; Lee, PH; Oh, YS; Park, HE; Park, IS; Ryu, DW; Song, IU; Yoo, IR	1
Abe, K; Hatanaka, N; Hishikawa, N; Matsuzono, K; Ohta, Y; Sato, K; Takamatsu, K; Takemi, T; Takemoto, M; Tsunoda, K; Yamashita, T	1
Haensch, CA; Isenmann, S; Jörg, J; Lerch, H	1
Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T; Nishibayashi, M; Suzuki, K	1
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nakazato, M; Nishii, R; Tamura, S; Wakamatsu, H; Yamashita, S	1
Morita, Y; Shibata, M; Shimizu, T; Suzuki, N; Takahashi, K	1
Arabia, G; Bagnato, A; Cascini, GL; Cipullo, S; Condino, F; Messina, D; Morelli, M; Morgante, L; Nicoletti, G; Novellino, F; Paglionico, S; Pugliese, P; Quattrone, A; Salsone, M	1
Kinuya, S; Matsuo, S; Nakajima, K; Taki, J; Yoshita, M	1
Mahowald, MW; Schenck, CH	1
Hosokawa, R; Kawamura, T; Kitagawa, N; Mizuta, E; Nishio, R; Oeda, T; Ohba, M; Sawada, H; Shimohama, S; Takahashi, R; Takeuchi, H; Yamakawa, K; Yamamoto, K	1
Fukui, M; Itokawa, K; Kato, R; Kinoshita, S; Shimazu, K; Sumita, N; Tamura, N; Yamamoto, T	1
Cabello-García, D; Carnero-Pardo, C; Escamilla-Sevilla, F; Gallego-Peinado, M; Gómez Río, M; Mínguez-Castellanos, A; Muñoz-Pasadas, M; Ortega-Léon, T; Ortega-Moreno, A; Pérez-Navarro, MJ; Rebollo-Aguirre, AC	1
Isales, CM; Mehta, SH; Morgan, JC; Prakash, R; Prisant, LM; Sethi, KD; Williams, H	1
Chung, EJ; Kim, BJ; Lee, GH; Lee, WY; Yoon, WT	1
Fukuyama, H	1
Ishibashi, K; Ishii, K; Ishiwata, K; Kanemaru, K; Mizusawa, H; Murayama, S; Oda, K; Saito, Y	1
Fukuda, T; Fukumitsu, N; Kiyono, Y; Suzuki, M	1
Rascol, O; Schelosky, L	1
Leite, MA; Nascimento, OJ	1
Imamura, T; Kashihara, K; Shinya, T	1
Mochio, S; Oka, H; Toyoda, C; Yogo, M	3
Hama, T; Hirayama, M; Hori, N; Nakamura, T; Sobue, G; Takamori, M; Uchida, K; Yamashita, F	1
Iijima, M; Iwata, M; Kobayakawa, T; Momose, M; Osawa, M; Saito, S; Uchiyama, S	1
Cason, E; Fagioli, G; Gabellini, A; Giordano, A; Treglia, G	1
Abbruzzese, G; Bandettini di Poggio, M; Marchese, R; Marini, C; Morbelli, SD; Nobili, F; Pomposelli, E; Sambuceti, G; Villa, G	1
Braune, S; Del Tredici, K; Jost, WH; Landvogt, C	1
Hama, T; Hirayama, M; Nakamura, T; Sobue, G; Uchida, K; Watanabe, H; Yamashita, F	1
Kajimoto, Y; Kondo, T; Miwa, H	1
Abe, T; Högl, B; Inoue, Y; Kitayama, M; Miyoshi, H; Nakashima, K; Nomura, T; Uemura, Y	1
Hamasaki, T; Kuratsu, J; Shiraishi, SY; Yamada, K	1
Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T	1
Buongiorno, M; De la Cerda, A; Ezquerra, M; Gaig, C; Lomeña, F; Martí, MJ; Muxí, A; Navales, I; Paredes, P; Santacruz, P; Tolosa, E; Valldeoriola, F	1
Kishi, M; Ogawa, E; Sakakibara, R; Tateno, T; Terada, H	1
Högl, B; Inoue, Y; Nakashima, K; Nomura, T	1
de la Cerda, A; Domenech, B; Gaig, C; Lomeña, F; Muxí, A; Navales, I; Paredes, P; Pons, F; Solà, O; Tolosa, E; Valldeoriola, F	1
Chung, SW; Kim, JS; Kim, YD; Lee, KS; Oh, YS	1
Antke, C; Beu, M; Müller, HW; Nikolaus, S; Schnitzler, A; Südmeyer, M; Wojtecki, L; Zizek, T	1
Hama, T; Hara, T; Hirayama, M; Nakamura, T; Sobue, G; Watanabe, H	1
Bae, SK; Chung, EJ; Kim, EG; Kim, MS; Kim, SJ; Oh, M; Oh, SJ; Seog, DH	1
Alzualde, A; Bergareche, A; Gorostidi, A; Goyenechea, E; López de Munain, A; Martí Massó, JF; Moreno, F; Poza, JJ; Rodríguez, F; Ruiz-Martínez, J	1
Abe, K; Fujii, D; Imai, Y; Kono, S; Manabe, Y; Narai, H; Omori, N; Sakai, Y; Tanaka, T	1
Nakamagoe, K; Takeda, T; Tamaoka, A; Watanabe, M	1
Cason, E; Cocciolillo, F; Di Giuda, D; Fagioli, G; Giordano, A; Stefanelli, A; Treglia, G	1
Baba, T; Hasegawa, T; Kikuchi, A; Konno, M; Sugeno, N; Takeda, A	1
Berganzo, K; Gómez-Esteban, JC; Iodice, V; Lezcano, E; Llorens, V; Low, D; Mathias, CJ; Sánchez-Manso, JC; Somme, JH; Tijero, B; Vichayanrat, E; Zarranz, JJ	1
Cason, E; Cocciolillo, F; Di Giuda, D; Giordano, A; Stefanelli, A; Treglia, G	1
Izawa, MO; Kajimoto, Y; Kondo, T; Miwa, H	1
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y	1
Inaba, A; Mizusawa, H; Orimo, S; Suzuki, M	1
Adamec, I; Habek, M; Klepac, N; Milivojević, I; Radić, B	1
Cason, E; Treglia, G	1
Chiaravalloti, A; Danieli, R; Di Biagio, D; Di Pietro, B; Olivola, E; Pierantozzi, M; Schillaci, O; Simonetti, G; Stampanoni, M; Stanzione, P; Stefani, A; Tavolozza, M	1
Furutani, Y; Hayano, T; Kinbara, T; Otani, N; Tanaka, S	1
Cho, JW; Choi, YY; Jang, W; Kim, HT; Kim, JS; Kim, JY; Kim, YH	1
Becker, G; Benecke, R; Braune, S; Büttner, T; Greulich, W; Klein, W; Mark, G; Müller, A; Rieke, J; Thümler, R	1
Hattori, H; Nakade, S; Orimo, S; Ozawa, E; Takahashi, A; Taki, K; Tsuchiya, K	1
Akincioglu, C; Tunc, T; Unlu, M	1
Hamada, K; Hirayama, M; Ieda, T; Ito, H; Kobayashi, R; Koike, Y; Sobue, G; Watanabe, H	1
Alibelli, MJ; Berry, I; Brefel-Courbon, C; Courbon, F; Montastruc, JL; Rascol, O; Senard, JM; Thalamas, C	1
Inoue, K; Mochio, S; Morita, M; Oka, H; Yoshioka, M	1
Campos, V; Gómez-Doblas, JJ; Gutiérrez-Hurtado, A; Jiménez-Hoyuela, JM; Medialdea, P; Rebollo, AC; Vila, E	1
Fujino, S; Higashi, K; Hirose, G; Hori, A; Kaito, M; Kakeshita, K; Kataoka, S; Miaki, M; Saiki, M; Saiki, S; Sakai, K; Taki, S	1
Aida, J; Hirokawa, K; Ito, Y; Ohkawa, S; Okada, Y; Yasuhara, M	1
Taki, J; Tonami, N; Yamada, M; Yoshita, M	1
Becker, G; Dillmann, U; Fuss, G; Jost, WH; Kirsch, CM; Möllers, MO; Samnick, S; Spiegel, J	1
Amino, T; Kojo, T; Orimo, S; Ozawa, E; Takahashi, A; Takahashi, H; Tsuchiya, K; Uchihara, T; Wakabayashi, K	1
Hamamoto, M; Katayama, Y; Nagashima, J; Nagayama, H; Ueda, M	1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F	1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Tamura, A; Udaka, F	1
Amino, T; Hattori, N; Kojo, T; Mizuno, Y; Orimo, S; Takahashi, A; Takahashi, H; Uchihara, T; Wakabayashi, K; Yokochi, M	1
Kaneko, E; Nagasaka, T; Ohashi, K; Ohta, E; Shindo, K; Shiozawa, Z; Sugimoto, T; Watanabe, H	1
Abo, M; Fukumitsu, N; Hashimoto, M; Inoue, K; Ito, Y; Kurita, A; Suzuki, M; Urashima, M	1
Haensch, CA; Jörg, J	1
Inoue, K; Mochio, S; Morita, M; Oka, H; Onouchi, K; Yoshioka, M	3
Arai, N; Kanazawa, I; Mitsui, J; Momose, T; Murayama, S; Saito, Y; Shibahara, J; Shimizu, J; Tsuji, S; Ugawa, Y	1
Komatsu, K; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F	1
Bang, OY; Huh, K; Joo, IS; Kim, JW; Lee, PH; Yoon, SN	1
Kashihara, K; Ohno, M; Tomita, S	1
Matsumoto, Y; Nakajima, K; Noguchi-Shinohara, M; Taki, J; Yamada, M; Yokoyama, K; Yoshita, M	1
Kashihara, K; Kawada, S; Ohno, M; Okumura, Y	1
Siderowf, A; Stern, MB	1
Kim, HJ; Lee, PH; Yeo, SH; Youm, HY	1
Ishii, K; Itokawa, K; Kawai, N; Shimazu, K; Tamura, N	1
Hirata, K; Inoue, Y; Miyamoto, M; Miyamoto, T; Suzuki, K; Usui, Y	1
Kim, JS; Lee, KS; Song, IU	1
Hirai, T; Inoue, K; Mochio, S; Morita, M; Oka, H; Onouchi, K; Suzuki, M; Urashima, M; Yoshioka, M	1
Boesch, S; Donnemilier, E; Heute, D; Köllensperger, M; Liener, C; Mair, KJ; Mueller, J; Poewe, W; Sawires, M; Scherfler, C; Schocke, MF; Seppi, K; Virgolini, I; Wenning, GK	1
Hamada, K; Hirayama, M; Ito, H; Koike, Y; Nakamura, T; Sobue, G; Takamori, M; Takeuchi, S; Watanabe, H	1
Irizawa, Y; Kitayama, M; Nakashima, K; Wada-Isoe, K	1
Akatsu, H; Fujita, M; Hashimoto, M; Ho, G; Masliah, E; Mizuno, H; Nakai, M; Waragai, M; Wei, J; Yokochi, F	1
Imamura, K; Kitamaya, M; Kowa, H; Nakashima, K; Wada-Isoe, K	1
Fukuyama, H; Kawanishi, T; Mitake, S; Oguri, T; Tachibana, N	1
Annesi, F; Annesi, G; Bagnato, A; Candiano, IC; Civitelli, D; Condino, F; D'Amelio, M; Loizzo, P; Morelli, M; Morgante, L; Nicoletti, G; Novellino, F; Petrone, A; Quattrone, A; Rocca, FE; Savettieri, G; Tarantino, P; Zappia, M	1
Hashimoto, M; Oka, H; Suzuki, M; Taira, K; Urashima, M	1
Kim, HT; Kim, JS; Kim, SH; Kim, YI; Lee, KS; Song, IU; You, IR	1
Doi, H; Hasegawa, Y; Miwa, S; Niimi, Y; Sobue, G; Takagi, S; Takahashi, A; Yamana, T	1
Papapetropoulos, S; Post, KK; Singer, C	1
Hakusui, S; Hasegawa, Y; Hirayama, M; Ikeda, M; Ito, K; Kato, T; Koike, Y; Takahashi, A	1
Satoh, A; Serita, T; Tsujihata, M	1
Hayabara, T; Kanzaki, N; Sato, K	1
Hayashi, M; Hirai, S; Yoshita, M	2
Yoshita, M	3
Iwasa, K; Nakajima, K; Tada, A; Takamori, M; Taki, J; Yoshikawa, H	1
Bathmann, J; Braune, S; Krause, T; Lehmann, M; Lücking, CH; Reinhardt, M	1
Iwanaga, K; Satoh, A; Satoh, H; Serita, T; Seto, M; Takashima, H; Tomita, I; Tsujihata, M	1
Mizusawa, H; Nakade, S; Orimo, S; Ozawa, E; Sugimoto, T	1
Braune, S; Lücking, CH; Reinhardt, M; Riedel, A; Schnitzer, R	1
Fujiwara, H; Matsuo, H; Nagashima, K; Nishida, H; Nishigaki, K; Noda, T; Takatsu, H; Wada, H; Watanabe, S	1
Hwang, EH; Komai, K; Matsunari, I; Nakajima, K; Sakajiri, K; Taki, J; Tonami, N; Yoshita, M	1
Braune, S; Jüngling, FD; Krause, TM; Reinhardt, MJ	1
Fujiwara, H; Matsuo, H; Murase, M; Nagashima, K; Nishida, H; Satomi, K; Takatsu, H; Watanabe, S	1
Ohmura, M	1
de Groot, AC; de Milliano, PA; Lie, KI; van Eck-Smit, BL	1
Allman, KC	1
Nakade, S; Oka, T; Orimo, S; Ozawa, E; Takahashi, H; Tsuchiya, K; Wakabayashi, K; Yoshimoto, M	1
Goldstein, DS	1

Reviews

22 review(s) available for 3-iodobenzylguanidine and Parkinson Disease

Article	Year
New development of diagnosis and treatment for Parkinson's disease. Rinsho shinkeigaku = Clinical neurology, 2017, 06-28, Volume: 57, Issue:6 Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Cell- and Tissue-Based Therapy; Deep Brain Stimulation; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Electric Stimulation Therapy; Genetic Therapy; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Neuroimaging; Olfaction Disorders; Parkinson Disease; Radionuclide Imaging; REM Sleep Behavior Disorder; Substantia Nigra; Ultrasonography	2017
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:5 Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders	2019
Neurological applications for myocardial MIBG scintigraphy. Nuclear medicine review. Central & Eastern Europe, 2013, Volume: 16, Issue:1 Topics: 3-Iodobenzylguanidine; Heart; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Sensitivity and Specificity; Sympathetic Nervous System	2013
[Initial diagnosis of Parkinson's disease - neuroradiological diagnosis]. Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11 Topics: 3-Iodobenzylguanidine; Brain; Cerebrovascular Circulation; Delayed Diagnosis; Diffusion Magnetic Resonance Imaging; Dopamine Plasma Membrane Transport Proteins; Early Diagnosis; Humans; Magnetic Resonance Imaging; Melanins; Molecular Imaging; Myocardial Perfusion Imaging; Neuroimaging; Parkinson Disease; Tomography, Emission-Computed, Single-Photon	2013
MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review. Parkinsonism & related disorders, 2014, Volume: 20, Issue:3 Topics: 3-Iodobenzylguanidine; Animals; Constipation; Humans; Hypotension, Orthostatic; Memory Disorders; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder	2014
Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:4 Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Diagnosis, Differential; Humans; Lewy Body Disease; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System	2008
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:11 Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Biomarkers; Diagnosis, Differential; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2008
123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Movement disorders : official journal of the Movement Disorder Society, 2009, Volume: 24 Suppl 2 Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals	2009
Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:4 Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Extrapyramidal Tracts; Heart; Humans; Lewy Bodies; Movement Disorders; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2010
Transcranial sonography in relation to SPECT and MIBG. International review of neurobiology, 2010, Volume: 90 Topics: 3-Iodobenzylguanidine; Humans; Parkinson Disease; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Transcranial	2010
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2012, Volume: 22, Issue:1 Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve	2012
Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:10 Topics: 3-Iodobenzylguanidine; Confidence Intervals; Data Interpretation, Statistical; Diagnosis, Differential; Humans; Image Processing, Computer-Assisted; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Tomography, Emission-Computed, Single-Photon	2011
123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism & related disorders, 2012, Volume: 18, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Neurodegenerative Diseases; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity	2012
[The clinical significance of MIBG myocardial scintigraphy in Parkinson disease]. Brain and nerve = Shinkei kenkyu no shinpo, 2012, Volume: 64, Issue:4 Topics: 3-Iodobenzylguanidine; Animals; Heart; Humans; Lewy Bodies; Parkinson Disease; Presynaptic Terminals; Radionuclide Imaging; Sympathetic Nervous System	2012
Early diagnosis of Parkinson's disease. Journal of neurology, 2002, Volume: 249 Suppl 3 Topics: 3-Iodobenzylguanidine; Affect; Biomarkers; Handwriting; Heart; Humans; Iron; Mood Disorders; Movement Disorders; Mutation; Olfaction Disorders; Parkinson Disease; Peripheral Nervous System Diseases; Psychomotor Performance; Radiopharmaceuticals; Risk Assessment; Risk Factors; Speech; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vision, Ocular	2002
[MIBG myocardial scintigraphy of Parkinson's disease and related diseases]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging	2004
Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Annals of nuclear medicine, 2004, Volume: 18, Issue:6 Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System; Brain; Clinical Trials as Topic; Humans; Lewy Body Disease; Neurodegenerative Diseases; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2004
[A useful marker for differential diagnosis of Parkinson's disease--MIBG myocardial scintigraphy]. Rinsho shinkeigaku = Clinical neurology, 2004, Volume: 44, Issue:11 Topics: 3-Iodobenzylguanidine; Biomarkers; Diagnosis, Differential; Heart; Humans; Myocardium; Parkinson Disease; Radionuclide Imaging; Tyrosine 3-Monooxygenase	2004
Preclinical diagnosis of Parkinson's disease: are we there yet? Current neurology and neuroscience reports, 2006, Volume: 6, Issue:4 Topics: 3-Iodobenzylguanidine; Biomarkers; Dopamine; Genetic Testing; Humans; Mental Disorders; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Risk Assessment; Syndrome; Tomography, Emission-Computed, Single-Photon	2006
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:1 Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Diagnosis, Differential; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Myocardium; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2008
Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques. Parkinsonism & related disorders, 2008, Volume: 14, Issue:7 Topics: 3-Iodobenzylguanidine; Heart Diseases; Humans; Parkinson Disease; Phthalic Anhydrides; Positron-Emission Tomography; Primary Dysautonomias	2008
Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2001, Volume: 11, Issue:6 Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Sympathetic Nervous System	2001

Trials

16 trial(s) available for 3-iodobenzylguanidine and Parkinson Disease

Article	Year
Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes. Clinical nuclear medicine, 2019, Volume: 44, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; ROC Curve	2019
On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases. PloS one, 2016, Volume: 11, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Female; Heart Diseases; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Tomography, X-Ray Computed	2016
MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2009, Aug-15, Volume: 24, Issue:11 Topics: 3-Iodobenzylguanidine; Adenosine; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Galvanic Skin Response; Heart; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Respiration; Sensitivity and Specificity; Sympathetic Fibers, Postganglionic; Tomography, Emission-Computed, Single-Photon; Valsalva Maneuver	2009
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. Clinical nuclear medicine, 2010, Volume: 35, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging	2010
Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-15, Volume: 25, Issue:9 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Ergometry; Exercise Therapy; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Posture	2010
Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:9 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity	2011
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:5 Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Benzamides; Diagnosis, Differential; Humans; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tropanes	2011
[Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver]. Rinsho shinkeigaku = Clinical neurology, 2003, Volume: 43, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Heart; Humans; Iodine Radioisotopes; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Valsalva Maneuver	2003
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Longitudinal Studies; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2005
Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid. Annals of nuclear medicine, 2005, Volume: 19, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Gland	2005
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology, 2006, Jun-27, Volume: 66, Issue:12 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Confounding Factors, Epidemiologic; Diagnosis, Differential; Female; Humans; Japan; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2006
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology, 2006, Dec-26, Volume: 67, Issue:12 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder	2006
[Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Parkinson Disease; Radionuclide Imaging	1997
[Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Rinsho shinkeigaku = Clinical neurology, 1997, Volume: 37, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Sympathetic Nervous System	1997
Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. European journal of nuclear medicine, 2000, Volume: 27, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Coronary Circulation; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardium; Parkinson Disease; Peripheral Nervous System Diseases; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2000
Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. European journal of nuclear medicine, 2000, Volume: 27, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Lung; Male; Mediastinal Diseases; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2000

Other Studies

164 other study(ies) available for 3-iodobenzylguanidine and Parkinson Disease

Article	Year
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2021, Volume: 128, Issue:12 Topics: 3-Iodobenzylguanidine; Humans; Hypotension, Orthostatic; Intermediate Filaments; Parkinson Disease; REM Sleep Behavior Disorder	2021
Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern. Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:3 Topics: 3-Iodobenzylguanidine; Brain; Humans; Parkinson Disease; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2022
Association of plasma α-synuclein with cardiac Neuroscience letters, 2022, 01-23, Volume: 770 Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tropanes	2022
Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2022, Volume: 32, Issue:2 Topics: 3-Iodobenzylguanidine; Humans; Iodine; Multiple System Atrophy; Parkinson Disease; Prospective Studies	2022
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder. Journal of Parkinson's disease, 2022, Volume: 12, Issue:6 Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes	2022
Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up. Parkinsonism & related disorders, 2022, Volume: 101 Topics: 3-Iodobenzylguanidine; Dopamine; Follow-Up Studies; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder	2022
Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study. Parkinsonism & related disorders, 2022, Volume: 103 Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Biomarkers; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Humans; Japan; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder; Synucleinopathies	2022
Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD. Annals of neurology, 2023, Volume: 93, Issue:2 Topics: 3-Iodobenzylguanidine; Heart; Humans; Liver; Neurodegenerative Diseases; Parkinson Disease; PPAR alpha; Radiopharmaceuticals	2023
Dual-phase European journal of neurology, 2023, Volume: 30, Issue:2 Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Glucosylceramidase; Humans; Hypotension, Orthostatic; Mutation; Parkinson Disease; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon; Tropanes	2023
Reduced Journal of neurology, 2023, Volume: 270, Issue:9 Topics: 3-Iodobenzylguanidine; Heart; Humans; Parkinson Disease; Parotid Gland; Radiopharmaceuticals; Submandibular Gland	2023
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder. Journal of neurology, 2023, Volume: 270, Issue:9 Topics: 3-Iodobenzylguanidine; Humans; Intermediate Filaments; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; REM Sleep Behavior Disorder	2023
Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder. European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:11 Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Risk Factors	2023
[Association of Pathological Progression of Parkinson's Disease and the Thyroid Gland]. Brain and nerve = Shinkei kenkyu no shinpo, 2023, Volume: 75, Issue:8 Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Heart; Humans; Parkinson Disease; Radiopharmaceuticals	2023
Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease. Journal of the neurological sciences, 2023, Nov-15, Volume: 454 Topics: 3-Iodobenzylguanidine; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Glycated Hemoglobin; Humans; Parkinson Disease	2023
Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase? Neuro-degenerative diseases, 2019, Volume: 19, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies	2019
Sympathetic nervous activity and hemoglobin levels in de novo Parkinson's disease. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2020, Volume: 30, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Female; Hemoglobins; Humans; Hypotension, Orthostatic; Parkinson Disease; Sympathetic Nervous System	2020
Usefulness of 5 Minutes Current radiopharmaceuticals, 2020, Volume: 13, Issue:2 Topics: 3-Iodobenzylguanidine; Brain; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Time Factors	2020
Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease. PloS one, 2020, Volume: 15, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Pressure; Female; Fluorine Radioisotopes; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Parkinson Disease; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tropanes	2020
Differences in correlations of depression and anhedonia with cardiovascular sympathetic functions during a head-up tilt test in drug-naïve Parkinson's disease patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020, Volume: 41, Issue:10 Topics: 3-Iodobenzylguanidine; Anhedonia; Depression; Humans; Parkinson Disease; Pharmaceutical Preparations	2020
Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism? Clinical nuclear medicine, 2020, Volume: 45, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes	2020
Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease. Current radiopharmaceuticals, 2021, Volume: 14, Issue:1 Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Early Diagnosis; Female; Heart; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results	2021
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies. Parkinsonism & related disorders, 2020, Volume: 81 Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Peripheral Nerves; Phosphorylation; Pure Autonomic Failure; Radionuclide Imaging; Radiopharmaceuticals; Skin	2020
Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-up. Parkinsonism & related disorders, 2021, Volume: 84 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Vesicular Transport Proteins; Young Adult	2021
Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy. Neurobiology of disease, 2021, Volume: 153 Topics: 3-Iodobenzylguanidine; Adult; Aged; alpha-Synuclein; Autonomic Fibers, Postganglionic; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Fibers; Neural Conduction; Parkinson Disease; Peripheral Nervous System; Phosphorylation; Radionuclide Imaging; Radiopharmaceuticals; Skin	2021
Interobserver Agreement in the Diagnosis of Parkinson Disease with Cardiac Journal of nuclear medicine technology, 2021, Volume: 49, Issue:3 Topics: 3-Iodobenzylguanidine; Heart; Humans; Iodine Radioisotopes; Observer Variation; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2021
Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease. Medicine, 2021, Aug-20, Volume: 100, Issue:33 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Parkinson Disease; Positron-Emission Tomography	2021
Combined use of dopamine transporter imaging (DAT-SPECT) and Journal of the neurological sciences, 2017, Apr-15, Volume: 375 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Severity of Illness Index; Statistics as Topic; Tropanes	2017
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nuclear medicine communications, 2017, Volume: 38, Issue:6 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; ROC Curve; Tomography, Emission-Computed, Single-Photon; Tropanes	2017
Clinical neurology and neurosurgery, 2017, Volume: 160 Topics: 3-Iodobenzylguanidine; Adult; Aftercare; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes	2017
Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study. Journal of the neurological sciences, 2017, Oct-15, Volume: 381 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Dementia; Dopamine Agents; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multivariate Analysis; Myocardium; Parkinson Disease; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Risk Factors	2017
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease. Neurology, 2018, 01-30, Volume: 90, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Caffeine; Case-Control Studies; Chromatography, Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Female; Humans; Male; Mass Spectrometry; Middle Aged; Mutation; Myocardial Perfusion Imaging; Parkinson Disease; Retrospective Studies; Severity of Illness Index	2018
Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study. Parkinsonism & related disorders, 2018, Volume: 50 Topics: 3-Iodobenzylguanidine; Adult; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Sensitivity and Specificity	2018
Cardiac Sympathetic Denervation Can Predict the Wearing-off Phenomenon in Patients with Parkinson Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Case-Control Studies; Disease Progression; Female; Heart; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2018
MIBG scintigraphy of the major salivary glands in multiple system atrophy. Parkinsonism & related disorders, 2018, Volume: 53 Topics: 3-Iodobenzylguanidine; Humans; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Salivary Glands; Sympathetic Nervous System	2018
Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2019, Volume: 29, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Early Diagnosis; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity	2019
Prospective study of relevance of Journal of neurology, 2018, Volume: 265, Issue:9 Topics: 3-Iodobenzylguanidine; Biomarkers; Clonidine; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2018
Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease. Nuclear medicine communications, 2018, Volume: 39, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nortropanes; Parkinson Disease; Radionuclide Imaging; Sensitivity and Specificity	2018
Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:2 Topics: 3-Iodobenzylguanidine; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Phenotype; Radionuclide Imaging; Retrospective Studies	2019
MIBG myocardial scintigraphy in progressive supranuclear palsy. Journal of the neurological sciences, 2019, 01-15, Volume: 396 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrophy; Brain Stem; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive	2019
Striatal dopamine activity and myocardial Parkinsonism & related disorders, 2019, Volume: 63 Topics: 3-Iodobenzylguanidine; Aged; Dopamine Plasma Membrane Transport Proteins; Female; Globus Pallidus; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals	2019
Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease. Acta neurologica Scandinavica, 2013, Volume: 128, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors	2013
Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease. PloS one, 2013, Volume: 8, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Diffusion; Female; Humans; Male; Multiple System Atrophy; Parkinson Disease; Putamen; Radionuclide Imaging	2013
Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? Parkinsonism & related disorders, 2013, Volume: 19, Issue:8 Topics: 3-Iodobenzylguanidine; Follow-Up Studies; Humans; Iodine Radioisotopes; Parkinson Disease; Radionuclide Imaging	2013
Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases. Annals of nuclear medicine, 2013, Volume: 27, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Biological Transport; Diagnosis, Differential; Female; Heart Diseases; Humans; Lewy Body Disease; Lung; Male; Middle Aged; Parkinson Disease; Prognosis; Radionuclide Imaging; Survival Analysis; Ventricular Dysfunction, Left	2013
Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Parkinsonism & related disorders, 2013, Volume: 19, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Female; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Norepinephrine; Parkinson Disease; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Skin; Surveys and Questionnaires; Sympathectomy; Valsalva Maneuver	2013
Thyroid MIBG uptake in Parkinson's disease with diabetes mellitus. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2013, Volume: 23, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Diabetes Complications; Diabetic Neuropathies; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland	2013
Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12 Topics: 3-Iodobenzylguanidine; Adult; Biological Transport; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Spinocerebellar Ataxias; Sympathetic Nervous System; Young Adult	2013
Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease? Journal of neurology, 2014, Volume: 261, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Parkinson Disease; Statistics, Nonparametric; Valsalva Maneuver	2014
123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease. Parkinsonism & related disorders, 2014, Volume: 20, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Smell; Tomography, Emission-Computed, Single-Photon; Tropanes	2014
Cardiac 123I-MIBG uptake in de novo Brazilian patients with Parkinson's disease without clinically defined dysautonomia. Arquivos de neuro-psiquiatria, 2014, Volume: 72, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Brazil; Chi-Square Distribution; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Retrospective Studies; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon	2014
Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. International journal of geriatric psychiatry, 2015, Volume: 30, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Psychotic Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2015
Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. BMC neurology, 2015, May-15, Volume: 15 Topics: 3-Iodobenzylguanidine; Aged; Brain; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2015
Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease. Journal of neurology, 2015, Volume: 262, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Female; Humans; Iodine Isotopes; Male; Motor Activity; Myocardium; Parkinson Disease; Radionuclide Imaging; Statistics as Topic; Thyroid Hormones	2015
Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease. Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes	2015
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms. CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:9 Topics: 3-Iodobenzylguanidine; Adult; Aged; Antiparkinson Agents; Autonomic Nervous System; Blood Pressure; Female; Hand Strength; Heart; Humans; Levodopa; Male; Middle Aged; Myocardial Perfusion Imaging; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Severity of Illness Index; Time Factors	2015
PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease. European neurology, 2015, Volume: 74, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals	2015
Cardiac (123)I-meta-iodo-benzyl-guanine in a patient with bipolar affective disorder, musical hallucinations and Parkinsonism. The Australian and New Zealand journal of psychiatry, 2016, Volume: 50, Issue:1 Topics: 3-Iodobenzylguanidine; Atrophy; Bipolar Disorder; Brain; Female; Hallucinations; Heart; Humans; Middle Aged; Music; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Metaiodobenzylguanidine Myocardial Scintigraphy Identifies Premotor Parkinson's Disease During a Negative Dopamine Transporter Scan. Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals	2015
Myocardial Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1 Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Female; Genetic Predisposition to Disease; Heart; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Polymorphism, Single Nucleotide; Radionuclide Imaging; Radiopharmaceuticals; Ubiquitin-Protein Ligases	2017
Increased body mass index associated with autonomic dysfunction in Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 24 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Body Mass Index; Female; Humans; Male; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Retrospective Studies	2016
Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease. Neurologia medico-chirurgica, 2016, Volume: 56, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Deep Brain Stimulation; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Nortropanes; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2016
24-Hour Ambulatory Blood Pressure Monitoring in SWEDDs Patients With Parkinsonism. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2016, Volume: 43, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography Scanners, X-Ray Computed	2016
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder. Journal of the neurological sciences, 2016, Mar-15, Volume: 362 Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Autonomic Nervous System Diseases; Blood Pressure; Female; Heart Rate; Humans; Hypotension, Orthostatic; Logistic Models; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder	2016
[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study. Rinsho shinkeigaku = Clinical neurology, 2016, 06-22, Volume: 56, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Disease Progression; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2016
Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 34 Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Parkinson Disease; Parotid Gland; Radionuclide Imaging; Submandibular Gland	2017
Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment. Journal of the neurological sciences, 2016, Nov-15, Volume: 370 Topics: 3-Iodobenzylguanidine; Baroreflex; Cardiovascular Diseases; Echocardiography; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Spirometry	2016
Comparison of Dopamine Transporter SPECT and 123I-MIBG Myocardial Scintigraphy to Assess Clinical Severity in Patients With Parkinson Disease. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2017
Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes. PloS one, 2016, Volume: 11, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Olfactory Perception; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Substantia Nigra; Ultrasonography, Doppler, Transcranial	2016
Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype? European journal of neurology, 2017, Volume: 24, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Cognition Disorders; Constipation; Cost of Illness; Female; Heart; Humans; Hypotension, Orthostatic; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder	2017
Potential multisystem degeneration in Asidan patients. Journal of the neurological sciences, 2017, Feb-15, Volume: 373 Topics: 3-Iodobenzylguanidine; Aged; Brain; Family; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Pedigree; Radiopharmaceuticals; Spinocerebellar Degenerations; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon; Tropanes	2017
Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Female; Heart; Heart Rate; Humans; Hypotension, Orthostatic; Male; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Spectrum Analysis; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon	2009
123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep, 2008, Volume: 31, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive	2008
Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy. Annals of nuclear medicine, 2008, Volume: 22, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Cerebrovascular Circulation; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon	2008
Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. Journal of the neurological sciences, 2009, Jan-15, Volume: 276, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Analysis of Variance; Autonomic Nervous System Diseases; Chi-Square Distribution; Electrocardiography; Female; Humans; Hypotension, Orthostatic; Linear Models; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Parkinson Disease; Radiopharmaceuticals; Sympathectomy	2009
Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait. Parkinsonism & related disorders, 2009, Volume: 15, Issue:5 Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Antiparkinson Agents; Disease Progression; Female; Gait; Gait Apraxia; Heart; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Treatment Outcome	2009
Subclinical REM sleep behavior disorder and its clinical and research implications. Sleep, 2008, Volume: 31, Issue:12 Topics: 3-Iodobenzylguanidine; Aged; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Risk Factors	2008
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. European journal of neurology, 2009, Volume: 16, Issue:2 Topics: 3-Iodobenzylguanidine; Cross-Sectional Studies; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity	2009
A case of sick sinus syndrome and autonomic failure with Parkinson's disease. Autonomic neuroscience : basic & clinical, 2009, Mar-12, Volume: 146, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Bradycardia; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Iodine Radioisotopes; Male; Parasympathetic Nervous System; Parkinson Disease; Positron-Emission Tomography; Pure Autonomic Failure; Sick Sinus Syndrome; Sinoatrial Node; Sympathetic Nervous System	2009
[Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders]. Neurologia (Barcelona, Spain), 2009, Volume: 24, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sympathectomy	2009
Diagnosis of pheochromocytoma in the setting of Parkinson disease. Nature reviews. Neurology, 2009, Volume: 5, Issue:6 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pheochromocytoma; Tomography, Emission-Computed, Single-Photon	2009
Is (123)I-MIBG cardiac scintigraphy a surrogate marker for Parkinson's disease? European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1 Topics: 3-Iodobenzylguanidine; Brain; Heart; Humans; Image Enhancement; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals	2010
Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Brain; Dopamine Antagonists; Female; Heart; Humans; Image Enhancement; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2010
Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism. Nuclear medicine and biology, 2009, Volume: 36, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Dopamine; Mice; Myocardium; Neostriatum; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Parkinson Disease; Time Factors; Tyrosine	2009
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. European journal of neurology, 2010, Volume: 17, Issue:2 Topics: 3-Iodobenzylguanidine; Diabetes Complications; Diabetes Mellitus; Glucose; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors	2010
Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. Parkinsonism & related disorders, 2010, Volume: 16, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Female; Gated Blood-Pool Imaging; Humans; Male; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder	2010
Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease. Journal of neurology, 2010, Volume: 257, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Odorants; Olfaction Disorders; Parkinson Disease; Pattern Recognition, Physiological; Physical Stimulation; Primary Dysautonomias; Radionuclide Imaging; Severity of Illness Index; Sex Factors	2010
Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2010, Volume: 20, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Blood Pressure; Disease Progression; Female; Heart Function Tests; Humans; Male; Middle Aged; Miotics; Multiple System Atrophy; Parkinson Disease; Pilocarpine; Pupil; Radionuclide Imaging; Radiopharmaceuticals; Reflex, Pupillary; ROC Curve	2010
Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-15, Volume: 25, Issue:9 Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Autonomic Nervous System Diseases; Case-Control Studies; Chi-Square Distribution; Female; Heart; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Smell	2010
Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension. European journal of neurology, 2011, Volume: 18, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Cardiovascular System; Female; Gated Blood-Pool Imaging; Heart; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Primary Dysautonomias; Valsalva Maneuver	2011
Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes. Neuro-degenerative diseases, 2010, Volume: 7, Issue:5 Topics: 3-Iodobenzylguanidine; Antithyroid Agents; Brain; Diagnosis, Differential; Early Diagnosis; False Negative Reactions; False Positive Reactions; Humans; Image Interpretation, Computer-Assisted; Movement Disorders; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2010
Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease. Parkinsonism & related disorders, 2010, Volume: 16, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Female; Heart; Humans; Linear Models; Male; Middle Aged; Myocardium; Parkinson Disease; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2010
Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease. Acta neurochirurgica, 2010, Volume: 152, Issue:12 Topics: 3-Iodobenzylguanidine; Adult; Aged; Arrhythmias, Cardiac; Deep Brain Stimulation; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Patient Selection; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Subthalamic Nucleus; Treatment Outcome	2010
Cardiac 123I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder. Parkinsonism & related disorders, 2011, Volume: 17, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder	2011
123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. Journal of neurology, 2011, Volume: 258, Issue:6 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Glycine; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Radionuclide Imaging; Radiopharmaceuticals; Serine; Severity of Illness Index; Smell; Statistics, Nonparametric	2011
Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease? Movement disorders : official journal of the Movement Disorder Society, 2011, Feb-15, Volume: 26, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging	2011
Authors' reply to the comments of Miyamoto et al. regarding "Cardiac (123)I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder". Parkinsonism & related disorders, 2011, Volume: 17, Issue:8 Topics: 3-Iodobenzylguanidine; Female; Heart; Humans; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder	2011
Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Observer Variation; Parkinson Disease; Reference Values; Reproducibility of Results; White People	2011
Camptocormia: as the first sign of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2011, Volume: 38, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Humans; Muscular Atrophy, Spinal; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Curvatures; Tropanes	2011
Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease? Movement disorders : official journal of the Movement Disorder Society, 2011, Aug-15, Volume: 26, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Abnormalities; Disability Evaluation; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics, Nonparametric	2011
Differences in myocardial sympathetic degeneration and the clinical features of the subtypes of Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2011, Volume: 18, Issue:7 Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Myocardium; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tremor	2011
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Taste	2011
Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease. Journal of the neurological sciences, 2011, Aug-15, Volume: 307, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Blood Pressure Determination; Chronobiology Disorders; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals	2011
Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease. European journal of neurology, 2011, Volume: 18, Issue:7 Topics: 3-Iodobenzylguanidine; Area Under Curve; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Sympathetic Nervous System	2011
Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism & related disorders, 2011, Volume: 17, Issue:9 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity	2011
SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism & related disorders, 2012, Volume: 18, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Severity of Illness Index; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2012
Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease. European journal of neurology, 2012, Volume: 19, Issue:3 Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Doppler, Transcranial	2012
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:22 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2011
Sick sinus syndrome and orthostatic hypotension in Parkinson's disease. Acta neurologica Belgica, 2012, Volume: 112, Issue:3 Topics: 3-Iodobenzylguanidine; Humans; Hypotension, Orthostatic; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Sick Sinus Syndrome	2012
Meta-analysis on MIBG scintigraphy in differential diagnosis between Parkinson's disease and neurodegenerative parkinsonism. Parkinsonism & related disorders, 2012, Volume: 18, Issue:6 Topics: 3-Iodobenzylguanidine; Female; Humans; Male; Myocardial Perfusion Imaging; Neurodegenerative Diseases; Parkinson Disease; Radiopharmaceuticals	2012
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. Molecular medicine reports, 2012, Volume: 6, Issue:6 Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Female; Heart; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathectomy; Tremor	2012
Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease. Annals of nuclear medicine, 2013, Volume: 27, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Asian People; Cardiovascular Diseases; Female; Heart; Humans; Male; Parkinson Disease; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Retrospective Studies	2013
Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System	2013
[123I] meta-iodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Basal Ganglia; Cerebral Cortex; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals	2003
Cardiac innervation and clinical correlates in idiopathic Parkinson's disease. Nuclear medicine communications, 2003, Volume: 24, Issue:3 Topics: 3-Iodobenzylguanidine; Activities of Daily Living; Adult; Aged; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reference Values	2003
Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:4 Topics: 3-Iodobenzylguanidine; Age Factors; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Heart Diseases; Humans; Male; Mediastinum; Middle Aged; Parkinson Disease; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Time Factors	2003
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:8 Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Female; Ganglia, Sympathetic; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2003
[Early alterations of adrenergic cardiac function in Parkinson's disease]. Neurologia (Barcelona, Spain), 2004, Volume: 19, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2004
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. Journal of the neurological sciences, 2004, May-15, Volume: 220, Issue:1-2 Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Enzyme Inhibitors; Female; Gait Ataxia; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Phenotype; Radionuclide Imaging; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tremor	2004
Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathology international, 2004, Volume: 54, Issue:9 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Ganglia, Autonomic; Heart; Humans; Lewy Bodies; Lewy Body Disease; Male; Parkinson Disease; Radionuclide Imaging; Sinoatrial Node	2004
FP-CIT and MIBG scintigraphy in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Brain; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes	2005
Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy. Autonomic neuroscience : basic & clinical, 2005, Apr-29, Volume: 119, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Liver; Lung; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Thyroid Gland	2005
Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Ganglia, Sympathetic; Heart; Humans; Male; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ubiquitin-Protein Ligases	2005
Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Disability Evaluation; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System	2005
Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Journal of the neurological sciences, 2006, Jan-15, Volume: 240, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Demography; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies	2006
Beat-to-beat blood pressure analysis after premature ventricular contraction indicates sensitive baroreceptor dysfunction in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:4 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Middle Aged; Parkinson Disease; Pressoreceptors; Radiopharmaceuticals; Regional Blood Flow; Tilt-Table Test; Ventricular Premature Complexes	2006
Cardiovascular dysautonomia in de novo Parkinson's disease. Journal of the neurological sciences, 2006, Feb-15, Volume: 241, Issue:1-2 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Baroreflex; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture; Spectrum Analysis; Valsalva Maneuver	2006
Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Autonomic Nervous System Diseases; Ganglia, Sympathetic; Heart; Humans; Iodine Radioisotopes; Lewy Bodies; Male; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Spinal Cord; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System; Wallerian Degeneration	2006
Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy. Acta neurologica Scandinavica, 2006, Volume: 113, Issue:4 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Baroreflex; Cardiovascular System; Case-Control Studies; Humans; Iodine Radioisotopes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Valsalva Maneuver	2006
Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms? Parkinsonism & related disorders, 2006, Volume: 12, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Constipation; Data Interpretation, Statistical; Disability Evaluation; Female; Heart; Humans; Hypotension, Orthostatic; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Diseases	2006
Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Diagnosis, Differential; Essential Tremor; Female; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2006
Dropped head syndrome in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Head Movements; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Retrospective Studies; Syndrome	2006
Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Dementia; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2006
Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Odorants; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Smell; Statistics as Topic	2006
Parkinsonism in type I Gaucher's disease. Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:20 Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Brain; Fluorodeoxyglucose F18; Gaucher Disease; Heart; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2006
Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease. Journal of the neurological sciences, 2007, Mar-15, Volume: 254, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Arteries; Autonomic Nervous System Diseases; Baroreflex; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Female; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Reflex, Abnormal; Sympathetic Fibers, Postganglionic	2007
Dopa-responsive camptocormia in a patient with multiple system atrophy. Parkinsonism & related disorders, 2008, Volume: 14, Issue:2 Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Female; Heart; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Multiple System Atrophy; Parkinson Disease; Posture; Radionuclide Imaging; Radiopharmaceuticals	2008
Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations. Movement disorders : official journal of the Movement Disorder Society, 2007, Jul-30, Volume: 22, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Analysis of Variance; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Diseases; Female; Hallucinations; Humans; Male; Middle Aged; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tilt-Table Test	2007
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Movement disorders : official journal of the Movement Disorder Society, 2007, Sep-15, Volume: 22, Issue:12 Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Area Under Curve; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Heart; Humans; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tilt-Table Test; Time Factors	2007
Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease. Journal of the neurological sciences, 2007, Dec-15, Volume: 263, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathectomy; Sympathomimetics	2007
Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease. Journal of the neurological sciences, 2008, Jan-15, Volume: 264, Issue:1-2 Topics: 3-Iodobenzylguanidine; Age Factors; Age of Onset; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Comorbidity; Down-Regulation; Female; Hallucinations; Heart; Heart Conduction System; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Multivariate Analysis; Parkinson Disease; Predictive Value of Tests; Radionuclide Imaging; Sympathetic Fibers, Postganglionic	2008
Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neuroscience letters, 2007, Sep-20, Volume: 425, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intracellular Signaling Peptides and Proteins; Iodine Isotopes; Male; Middle Aged; Oncogene Proteins; Parkinson Disease; Protein Deglycase DJ-1; Radionuclide Imaging	2007
Serum heart-fatty acid binding protein levels in patients with Lewy body disease. Journal of the neurological sciences, 2008, Mar-15, Volume: 266, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Diagnosis, Differential; Dopamine Agonists; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon	2008
Decrease in myocardial 123I-MIBG radioactivity in REM sleep behavior disorder: two patients with different clinical progression. Sleep medicine, 2008, Volume: 9, Issue:5 Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Disease Progression; Electrocardiography; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Sympathetic Fibers, Postganglionic	2008
Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23, Issue:1 Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; DNA Mutational Analysis; Female; Galvanic Skin Response; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Movement Disorders; Myocardium; Oncogene Proteins; Parkinson Disease; Parkinsonian Disorders; Point Mutation; Promoter Regions, Genetic; Protein Deglycase DJ-1; Protein Kinases; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Severity of Illness Index; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon; Ubiquitin-Protein Ligases	2008
Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. Neuroreport, 2007, Nov-19, Volume: 18, Issue:17 Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Hypokinesia; Male; Mediastinum; Middle Aged; Myocardium; Parkinson Disease; Phenotype; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis	2007
Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. Journal of the neurological sciences, 2008, Jul-15, Volume: 270, Issue:1-2 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Female; Gait; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Parkinson Disease; Posture; Prospective Studies; Radionuclide Imaging; Severity of Illness Index; Speech; Statistics as Topic; Sympathectomy	2008
[Relationship between cardiac 123I-metaiodobenzylguanidine scintigraphy and cardiovascular autonomic function test (standing test) in Parkinson's disease]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Diagnostic Techniques, Neurological; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2008
A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. Journal of the autonomic nervous system, 1995, Jun-25, Volume: 53, Issue:2-3 Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Isoproterenol; Male; Middle Aged; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Regional Blood Flow; Sympathetic Nervous System; Sympatholytics; Sympathomimetics	1995
Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease. Clinical nuclear medicine, 1997, Volume: 22, Issue:10 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Coronary Circulation; Droxidopa; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Parkinson Disease; Pergolide; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon	1997
Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease. Nuclear medicine communications, 1998, Volume: 19, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Tissue Distribution	1998
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. Journal of the neurological sciences, 1998, Feb-18, Volume: 155, Issue:1 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Supranuclear Palsy, Progressive	1998
Decreased myocardial 123I-MIBG uptake in Parkinson's disease. Acta neurologica Scandinavica, 1998, Volume: 97, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Case-Control Studies; Disease Progression; Female; Heart; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Myocardium; Parkinson Disease; Sympathetic Nervous System; Sympatholytics; Tomography, Emission-Computed, Single-Photon	1998
Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta neurologica Scandinavica, 1998, Volume: 97, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Case-Control Studies; Female; Heart; Humans; Iodine Radioisotopes; Male; Myocardium; Norepinephrine; Parkinson Disease; Sympathetic Nervous System; Sympatholytics; Tomography, Emission-Computed, Single-Photon	1998
Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Central Nervous System Diseases; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System	1999
(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 67, Issue:2 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System; Echocardiography; Electrocardiography, Ambulatory; Heart; Humans; Iodine Radioisotopes; Middle Aged; Nervous System Diseases; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	1999
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology, 1999, Sep-22, Volume: 53, Issue:5 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	1999
Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Aged; Animals; Autonomic Nervous System Diseases; Case-Control Studies; Dopamine Agents; Female; Heart; Humans; Iodine Radioisotopes; Male; Mice; Mice, Inbred C57BL; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Time Factors	2000
Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy. Neurology, 2000, May-09, Volume: 54, Issue:9 Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Humans; Multiple System Atrophy; Myocardium; Parkinson Disease; Predictive Value of Tests; Radionuclide Imaging	2000
Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA, 2000, Jul-05, Volume: 284, Issue:1 Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Male; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2000
Loss of 123I-metaiodobenzylguanidine uptake by the heart in Parkinson's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:8 Topics: 3-Iodobenzylguanidine; Heart; Humans; Neurodegenerative Diseases; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals	2000
Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:9 Topics: 3-Iodobenzylguanidine; Heart; Humans; Myocardium; Parkinson Disease; Publishing; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System	2000
Metoprolol-induced changes in myocardial (123)I-metaiodobenzylguanidine uptake in Parkinson's disease. Circulation, 2000, Nov-14, Volume: 102, Issue:20 Topics: 3-Iodobenzylguanidine; Anti-Arrhythmia Agents; Autonomic Nervous System Diseases; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Metoprolol; Middle Aged; Myocardium; Parkinson Disease; Tomography, Emission-Computed, Single-Photon	2000
Metoprolol-induced changes in myocardial (123)I-metaiodobenzylguanidine uptake in Parkinson's disease. Circulation, 2001, Aug-14, Volume: 104, Issue:7 Topics: 3-Iodobenzylguanidine; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Metoprolol; Myocardium; Norepinephrine; Parkinson Disease	2001
Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology, 2001, Sep-25, Volume: 57, Issue:6 Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Tyrosine 3-Monooxygenase	2001